Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Peptide Pool Concepts from Discovery to the Clinic

Peptide Pool Concepts from Discovery to the Clinic Published on 01/06/2021 SpotMix™ Antigen Discovery Pools for fast vaccine target identification & deep antigen profiling in cancer, infection, autoimmunity & more PepMix™ Purified Peptide Pools (catalog & cust

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Peptide Pool Concepts from Discovery to the Clinic

Published on 01/06/2021

SpotMix™ Antigen Discovery Pools for fast vaccine target identification & deep antigen profiling in cancer, infection, autoimmunity & more

PepMix™ Purified Peptide Pools (catalog & customized) for immune monitoring, T cell expansion & methods development

Clinical PepMix™ Peptide Pools for development of cell therapy, clinical trial immune monitoring & immune diagnostics

Matrix Pools for rapid epitope discovery with minimal sample consumption

Rapid assembly of multiple, small scale, low cost antigen peptide pools

Guaranteed peptide identity, pool content and purity level

Regulated manufacturing for clinical applications

Scaled peptide pools from micrograms to multi-grams

ADCF policies, line clearance, and complete batch documentation available

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Research context

Read sources and limitations before applying a claim.

Research Applications

Understanding the role of cellular proteins and HCMV genes in the context of pp65 provides insights into: The mechanisms of immune evasion by HCMV. Development of antiviral strategies targeting pp65. Broader implications for studying opportunistic infections in immunocompromised individuals.

Source: jpt.com ↗

High-Purity Peptides for Accurate Research

Each peptide in the PepMix™ Human (Melan-A/MART-1) pool is purified to development grade with a minimum purity of 70% (HPLC/MS), averaging 85% purity. This high standard ensures that your research results are reliable and reproducible, allowing for precise stimulation and analysis of T-cell responses.

Source: jpt.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Potential benefits

Benefits of Using PepMix™ Peptide Pools

When you choose PepMix™ Human MOG1-125 peptide pool, you benefit from: Stringent Quality Control: Each peptide is rigorously tested for identity and purity. Comprehensive Documentation: Certificates of Analysis (CoA) and HPLC-MS data provided for every batch. Batch-to-Batch Consistency: Ensures reliable results across multiple experiments. Elimination of False Positives: Prevents unwanted T-cell responses from contaminating peptides. Minimized Toxicity: Free from toxic inhibitors that could impair T-cell activity. Low Endotoxin Levels: Processed under stringent low-biocontamination conditions. Animal-Derived Component-Free (ADCF) Policy: Ensures compliance with ADCF requirements. HLA-Independent Stimulation: Utilizes antigen-spanning peptide pools for broad applicability.

Source: jpt.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Continue learning

Related guides